NCT05147519 (MOCHI) is a clinical trial of Novel interventions to achieve HIV remission in HIV Infections, sponsored by Henry M. Jackson Foundation for the Advancement of Military Medicine.

Who is sponsoring NCT05147519?

NCT05147519 is sponsored by Henry M. Jackson Foundation for the Advancement of Military Medicine.

What drugs are being tested in NCT05147519?

Interventions in NCT05147519: Novel interventions to achieve HIV remission.

What condition does NCT05147519 study?

NCT05147519 studies HIV Infections.

Is NCT05147519 still recruiting?

NCT05147519 is currently recruiting now. Last updated 6 March 2025.

Last reviewed 2025-03-06 · How we verify

NCT05147519: MOCHI

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Protocol RV 583 Multinational Observational Cohort of HIV and Other Infections

Recruiting now Last updated 6 March 2025

What this trial tests

trial testing Novel interventions to achieve HIV remission in HIV Infections in 2,500 participants. Currently enrolling.

Timeline

5 November 2021

Primary endpoint
30 June 2027

30 June 2032

Quick facts

Lead sponsor	Henry M. Jackson Foundation for the Advancement of Military Medicine
Status	Recruiting now
Study type	OBSERVATIONAL
Enrollment	2,500
Start date	5 November 2021
Primary completion	30 June 2027
Estimated completion	30 June 2032
Sites	3 locations across Philippines, Kenya, Uganda

Drugs / interventions tested

Novel interventions to achieve HIV remission

Conditions studied

HIV Infections — all drugs for HIV Infections →

Sponsor

Henry M. Jackson Foundation for the Advancement of Military Medicine

Who can join

Adults 14 to 55, any sex, with HIV Infections. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Multinational Observational Cohort of HIV and other Infections (MOCHI). This observational study is to gain information regarding the number of new HIV infections among people who engage in behaviors that make them vulnerable to acquiring HIV across multiple international sites.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Pre-exposure prophylaxis implementation gaps among people vulnerable to HIV acquisition: a cross-sectional analysis in two communities in western Kenya, 2021-2023.
Romo ML, Schluck G, Kosgei J, Akoth C, et al · · 2024 · cited 2× · PMID 39496511 · DOI 10.1002/jia2.26372
Limited awareness and use of HIV post-exposure prophylaxis among people vulnerable to HIV acquisition in Western Kenya: a cross-sectional analysis.
Schluck G, Romo ML, Kosgei J, Thigpen MC, et al · · 2025 · cited 1× · PMID 40569897 · DOI 10.1002/jia2.26472

Verify or expand the search:

Other recruiting trials for HIV Infections

Currently open trials in the same condition.

NCT07225530 — Implementation of Screen, Treat, and Triage for Women Living With HIV in La Romana (iSTAR) · NA · recruiting
NCT07202546 — A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study) · Phase 2 · recruiting
NCT06694753 — Safety and Immunogenicity Study of Three mRNAs Encoding HIV Immunogens in Adult Participants Without HIV and in Overall · Phase 1 · recruiting
NCT07235852 — Pilot Testing Into the Feasibility of the Developed Cognitive Behavioral Therapy Intervention · NA · recruiting
NCT06665646 — Clinical Trial to Evaluate the Safety and Immunogenicity of Hiltonol, Poly-ICLC-adjuvanted CD40.HIVRI.Env (VRIPRO) in Ad · Phase 1 · recruiting

Other Henry M. Jackson Foundation for the Advancement of Military Medicine trials

Trials by the same sponsor.

NCT07223684 — TDAP in Burn Patients (Group 2) · not yet recruiting
NCT07249762 — Surgical Critical Care Initiative (SC2i) Tissue and Data Acquisition Protocol (TDAP) in Burn Patients Improving the Robu · not yet recruiting
NCT06921707 — Pilot Trial for WounDx™ Clinical Decision Support Tool · NA · recruiting
NCT06885554 — Adjustment Disorders in the US Military: Disease Trajectories and ADNM-20-Mil Validation · NA · recruiting
NCT06855186 — Symptom-Targeted Approach to Rehabilitation for Concussion (STAR-C) · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05147519 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Henry M. Jackson Foundation for the Advancement of Military Medicine
Last refreshed: 6 March 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05147519.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing